60 Day FRN

9343

Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Generic Clearance for the Collection
of Qualitative Feedback on Agency
Service Delivery (OMB Control No.
0920–1071, Exp. 2/28/2021)—
Extension—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC/NCEZID is seeking a three-year
extension of OMB control No. 0920–
1071 to continue collecting routine
customer feedback on agency service
delivery. Executive Order 12862 directs
Federal agencies to provide service to
the public that matches or exceeds the
best service available in the private
sector. In order to work continuously to

ensure that our programs are effective
and meet our customers’ needs, the
National Center for Emerging and
Zoonotic Infectious Diseases, Centers for
Disease Control and Prevention (CDC)
(hereafter the ‘‘Agency’’) seeks to obtain
OMB approval of a generic clearance to
collect qualitative feedback on our
service delivery. By qualitative feedback
we mean information that provides
useful insights on perceptions and
opinions, but are not statistical surveys
that yield quantitative results that can
be generalized to the population of
study.
This collection of information is
necessary to enable the Agency to garner
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with our commitment to
improving service delivery. The
information collected from our
customers and stakeholders will help
ensure that users have an effective,
efficient, and satisfying experience with
the Agency’s programs. This feedback

will provide insights into customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Since getting approval in February
2018, NCEZID has utilized 0920–1071
ten separate times. The total number of
responses was 15,585. The total number
of burden hours was 2,525. Authorizing
legislation for this collection comes
from Section 301 of the Public Health
Service Act (42 U.S.C. 241). The
estimated annual burden hours
requested for this Extension are 3,850.
There is no cost to respondents other
than the time to participate.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondents

Form name

General public .................................................

Online surveys ...............................................
Focus groups .................................................
In-person surveys ...........................................
Usability testing ..............................................
Customer comment cards ..............................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–02948 Filed 2–11–21; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–21CT; Docket No. CDC–2021–
0006]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of

SUMMARY:

VerDate Sep<11>2014

17:27 Feb 11, 2021

Jkt 253001

government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
request for emergency clearance of the
information collection titled
Requirement for Negative Pre-Departure
Covid–19 Test Result or Documentation
of Recovery from Covid–19 for all
Airline or other Aircraft Passengers
arriving into the United States from any
foreign country. This collection
accompanies a CDC Order of the same
name and is designed to prohibit the
introduction into the United States of
any airline passenger departing from the
any foreign country unless the
passenger:
(1) Has a negative pre-departure test
result for COVID–19 (Qualifying Test),
or (2) has written or electronic
documentation of recovery from
COVID–19 in the form of a positive viral
test result and a letter from a licensed
health care provider or public health

PO 00000

Frm 00027

Fmt 4703

Sfmt 4703

1500
800
1000
1500
1000

Number of
responses per
respondent
1
1
1
1
1

Average
burden per
response
(in hours)
30/60
2
30/60
30/60
15/60

official stating that the passenger has
been cleared for travel.
DATES: CDC must receive written
comments on or before April 13, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0006 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and

E:\FR\FM\12FEN1.SGM

12FEN1

9344

Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices

instruments, contact Jeffrey M. Zirger, of
the Information Collection Review
Office, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.

SUPPLEMENTARY INFORMATION:

Proposed Project
Requirement for Negative PreDeparture Covid–19 Test Result or
Documentation of Recovery From
Covid–19 for all Airline or other Aircraft
Passengers Arriving into the United
States from any Foreign Country—
New—National Center for Emerging
Zoonotic and Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention (CDC).

VerDate Sep<11>2014

17:27 Feb 11, 2021

Jkt 253001

Background and Brief Description
This information collection
accompanies the Notice and Order
named above. Pursuant to 42 CFR 71.20
and as set forth in greater detail below,
this Notice and Order prohibit the
introduction into the United States of
any airline passenger departing from the
any foreign country unless the
passenger:
(1) Has a negative pre-departure test
result for COVID–19 (Qualifying Test),
or (2) has written or electronic
documentation of recovery from
COVID–19 in the form of a positive viral
test result and a letter from a licensed
health care provider or public health
official stating that the passenger has
been cleared for travel (Documentation
of Recovery).
The negative test must be a viral test
that was conducted on a specimen
collected during the three days
preceding the flight’s departure from a
foreign country. Passengers must retain
written or electronic documentation
reflecting the Qualifying Test, or
Documentation of Recovery, presented
to the airline and produce such
documentation upon request to any U.S.
government official or a cooperating
state or local public health authority.
Pursuant to 42 CFR 71.31(b), the
Order constitutes a controlled free
pratique to any airline with an aircraft
arriving into the United States from any
foreign country. Pursuant to the
controlled free pratique, the airline must
comply with the following conditions in
order to receive permission for the
aircraft to enter and disembark
passengers in the United States:
• Airline or other aircraft operator
must verify that every passenger—two
years of age or older—onboard the
aircraft has attested to receiving a
negative Qualifying Test result or to
having recovered from COVID–19 after
previous SARS–CoV–2 infection and
being cleared to travel by a licensed
health care provider or public health
official.
• Airline or other aircraft operator
must confirm that every passenger
onboard the aircraft has documentation
of a negative Qualifying Test result or
Documentation of Recovery from
COVID–19.
Certain exemptions and waivers do
apply, and are as follows:
• Crew members of airlines or other
aircraft operators provided that they
follow industry standard protocols for
the prevention of COVID–19 as set forth
in relevant Safety Alerts for Operators
(SAFOs) issued by the Federal Aviation
Administration (FAA).

PO 00000

Frm 00028

Fmt 4703

Sfmt 4703

• Airlines or other aircraft operators
transporting passengers with COVID–19
pursuant to CDC authorization and in
accordance with CDC guidance.
• Federal law enforcement personnel
on official orders who are traveling for
the purpose of carrying out a law
enforcement function, provided they are
covered under an occupational health
and safety program in accordance with
CDC guidance. Those traveling for
training or other business purposes
remain subject to the requirements of
this Order.
• U.S. Department of Defense (DOD)
personnel, including military personnel
and civilian employees, dependents,
contractors (including whole aircraft
charter operators), and other U.S.
government employees when traveling
on DOD assets, provided that such
individuals are under competent
military or U.S government travel orders
and observing DOD precautions to
prevent the transmission of COVID–19
as set forth in Force Protection
Guidance Supplement 14—Department
of Defense Guidance for Personnel
Traveling During the Coronavirus
Disease 2019 Pandemic (December 29,
2020) including its testing guidance.
• Individuals and organizations for
which the issuance of a humanitarian
exemption is necessary based on both
(1) exigent circumstances where
emergency travel is required to preserve
health and safety (e.g., emergency
medical evacuations) and (2) where predeparture testing cannot be accessed or
completed before travel. Additional
conditions may be placed on those
granted such exemptions, including but
not limited to, observing precautions
during travel, providing consent to postarrival testing, and/or self-quarantine
after arrival in the United States, as may
be directed by federal, state, territorial,
tribal or local public health authorities
to reduce the risk of transmission or
spread.
CDC anticipates certain additional
cost burdens to respondents and record
keepers due to the requirements. These
costs fall into the following categories:
• Traveler testing and ancillary costs:
$9,136,480,000.
• Traveler deferred travel costs:
$44,370,000.
• Airline staff costs for digitizing
attestations: $12,257,000.
• Airline costs to store attestations:
$1,200–$1,050,000 a year depending on
size of airline and number of travelers.
Estimated burden hours associated
with this collection are 70,843,733.

E:\FR\FM\12FEN1.SGM

12FEN1

9345

Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name

Traveler (3rd Party Disclosure) .........

Attestation of a negative COVID–19
test/Documentation indicating
clearance for travel by a licensed
healthcare provider or public
health official.
Attestation of a negative COVID–19
test/Documentation indicating
clearance for travel by a licensed
healthcare provider or public
health official.
Request Exemption on Urgent Humanitarian Basis.

Airline Desk Agent ............................

Traveler .............................................
Total ...........................................

...........................................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–02951 Filed 2–11–21; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–21CM; Docket No. CDC–2021–
0009]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National Center
for Health Statistics’ Research and
Development Survey (RANDS) during
COVID–19—Round 3. The Research and
Development Survey (RANDS) is
designed to quickly obtain and
disseminate information about selected
population health characteristics during
the ongoing coronavirus pandemic, and
to provide documentation supporting
the validity of pandemic-related survey

SUMMARY:

VerDate Sep<11>2014

17:27 Feb 11, 2021

Jkt 253001

Number of
responses per
respondent

Number of
respondents

Type of respondent

Frm 00029

Fmt 4703

Total burden
(in hours)

34,000,000

1

2

68,000,000

34,000,000

1

5/60

2,833,333

5,200

1

2

10,400

........................

........................

........................

70,843,733

questions, including questions, such as
those on telehealth access and use, that
will continue to be important for public
health after the pandemic.
DATES: Written comments must be
received on or before April 13, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0009 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct

PO 00000

Average
burden per
response
(in hours)

Sfmt 4703

or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
National Center for Health Statistics
Research and Development Survey
(RANDS) during COVID–19 (Round 3)—
New—National Center for Health
Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).

E:\FR\FM\12FEN1.SGM

12FEN1